A kind of polyamide-imide drug-loaded nanoparticles and its application

A drug-loaded nano-imide technology, applied in the field of anti-tumor drugs, can solve the problems of unguaranteed therapeutic effect, cumbersome multi-step synthesis and availability of purification, and achieve the effect of improving efficiency

Active Publication Date: 2021-11-09
WUXI PEOPLES HOSPITAL
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] It is worth noting that higher drug loading does not guarantee better therapeutic effect, because the physical and chemical properties of nanocarriers are also related to the cellular uptake of nanocarriers and subsequent targeted drug release.
Yuan et al. described a polymeric prodrug based on conjugated polyelectrolytes (CPEs) followed by DOX linkages, but tedious multi-step synthesis and purification made its availability challenging.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of polyamide-imide drug-loaded nanoparticles and its application
  • A kind of polyamide-imide drug-loaded nanoparticles and its application
  • A kind of polyamide-imide drug-loaded nanoparticles and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Synthesis of DSSP-OH: Dissolve 2,2'-dipyridyl disulfide (5.6 g, 25.5 mmol) in 30 mL of methanol, add 0.5 mL of glacial acetic acid as a catalyst, add mercaptoethanol (1.34 g, 17.1 mmol) in 10 ml of methanol, and stirred at room temperature in the dark for 3 hours, after the reaction, the mixture was evaporated in vacuo to a yellow oil, using ethyl acetate: hexane = 3: 7 (v / v) The eluent, the crude product was purified by silica gel chromatography, yield: 54.8%, 1 HNMR (400MHz, chloroform-d) δ8.52(ddd, 1H), 7.61(m, 1H), 7.40(dt, 1H), 7.15(m, 1H), 5.77(t, 1H), 3.83(m, 2H ), 2.95(m, 2H);

[0045] Synthesis of CPT-DSSP: CPT (2.0 g, 5.74 mmol), 4-dimethylaminopyridine (DMAP, 2.10 g, 17.2 mmol) and triphosgene (0.567 g, 1.92 mmol) were suspended in 50 mL of anhydrous dichloromethane , and stirred at room temperature under argon for 30 minutes, then, a solution of DSSP-OH (1.18 g, 6.31 mmol) dissolved in anhydrous tetrahydrofuran (THF) was added dropwise to the above mixture...

Embodiment 2

[0053] In vitro drug release: reduction-responsive drug release kinetics from P1-P3 PDNPs by dialysis method. Typically, 1 mL of P1-P3 PDNPs stock solution was added to dialysis tubing (MWCO: 3500 Da) and dialyzed against PBS (10 mM) at 37 °C. For each PDNPs, different concentrations of GSH (2 µM, 5 mM and 10 mM) were used in dialysis. At various predetermined time points, aliquots of the solution were collected and replaced with the same volume of PBS. According to the fluorescence spectrophotometer (E x =370nm,E m = 435nm) to calculate the amount of released CPT. In addition to DOX fluorescence detection wavelength, E x =488nm,E m =591nm, the in vitro drug release of dual-loaded P1-P3 PDNPs was determined by the same method.

[0054] Cell culture: Mouse breast cancer cells (4T1 cells), cervical cancer cells (HeLa cells) and human fibrosarcoma cells (HT-1080 cells) were obtained from the cell bank of Shanghai Institute of Cell Biology, China. Cells were cultured in Dul...

Embodiment 3

[0059] The experimental result of embodiment 1 and embodiment 2:

[0060]Synthesis and characterization of PAI-CPT prodrug: This study used the previous research method to combine thiolactone maleimide monomer with 4,7,10-trioxy-1,13-tridecanediamine (diamine 220) Equimolar ratio condensation polymerization to synthesize aliphatic PAI (polyamide-imide), the synthetic route diagram is shown in figure 2 . Quantitative characterization of the aminolysis of thiolactone and amine-maleimide-Michael additions allows a very efficient synthesis of PAIs and facilitates the in situ one-pot modification of PAIs. Prior to PAI-CPT coupling, pyridyl disulfide-modified CPT (i.e. CPT-DSSP) prodrugs were synthesized by a two-step process with an overall yield of about 33%, 1 H and 13 C NMR results confirmed its chemical structure (see figure 1 ).

[0061] In the present invention, due to the presence of the pyridine disulfide moiety, the CPT-DSSP prodrug can not only release CPT in a redu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses a polyamide-imide drug-loaded nanoparticle and its application. The polyamide-imide drug-loaded nanoparticle has a structural formula as shown in formula (I), wherein the R is R 1 or R 2 , the R 1 Be the camptothecin modified by mercapto and pyridyl disulfide, the R 2 for PEG 500 , the R 1 with R 2 The molar ratio is (10-40): (60-90); x is an integer of 1-7, and y is an integer of 1-3. The polyamide-imide drug-loaded nanoparticles were rapidly internalized within 2 hours, and due to the disulfide linkage between the PAI scaffold and the drug, reduction-responsive drug release could be achieved. In addition, PAI-CPT PNDs can be used as Nanocarriers loaded with other anticancer drugs (such as DOX) were used in combination chemotherapy and showed synergistic therapeutic effects.

Description

technical field [0001] The invention belongs to the technical field of antineoplastic drugs, in particular to a polyamide-imide drug-loaded nanoparticle and its application. Background technique [0002] Although small-molecule drug chemotherapy is one of the important paradigms for cancer therapy, it often exhibits poor bioavailability and uncontrollable pharmacokinetics, resulting in severe side effects and limited therapeutic efficacy. An effective strategy to address these issues is the use of nanoformulations, either by chemically coupling drugs to nanomaterials or by physically encapsulating drugs in nanocarriers. Compared with inorganic materials, polymer nanocarriers have good biocompatibility and tunable degradability, and are a promising drug delivery system for tumor chemotherapy [0003] It is worth noting that higher drug loading does not guarantee better therapeutic effects, because the physical and chemical properties of nanocarriers are also related to the c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityPatents(China)
IPC IPC(8): A61K47/69A61K31/704C08G73/14A61P35/00A61K31/4745
CPCA61K31/4745A61K31/704A61K47/6935A61P35/00C08G73/14A61K2300/00
Inventor李苁杨树东
OwnerWUXI PEOPLES HOSPITAL